Organization · Family Office
Dendis Capital
Dendis Capital is a family-run investment endowment fund based in the Czech Republic, focusing on innovative projects in life sciences and healthcare. It invests in both established growth companies and early-stage startups.
Overview
What Dendis Capital does
What Dendis Capital is
Dendis Capital is a family-run investment endowment fund based in the Czech Republic, focusing on innovative projects in life sciences and healthcare. It invests in both established growth companies and early-stage startups.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder
- Last reviewed
- April 3, 2026
Official channels
Find Dendis Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Dendis Capital as a funder
Investment thesis
Dendis Capital focuses on developing and supporting innovative projects in life sciences and healthcare, particularly through strategic investments in startups and established companies with growth potential.
Focus narrative
Dendis Capital invests in established companies with growth potential and supports innovative environments through strategic investments in startups. The foundation is particularly interested in projects that apply innovative technologies in life sciences, diagnostics, medical devices, drug and vaccine development, telemedicine, and the use of artificial intelligence in healthcare.
Focus and fit
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Notable portfolio companies include: CasInvent: Developing selective inhibitors for treating leukemia and other cancers; Groundcom: Creating a global network of ground stations for real-time satellite communication; HTG Medical: Streamlining urine output measurement in healthcare; AI|ffinity: Enhancing drug discovery processes using NMR, AI, and cheminformatics; NuvinkaDx: Providing innovative diagnostic solutions; Alvie: Optimizing pesticide use through advanced algorithms; KARDI AI: Offering affordable home heart monitoring using AI technology.
Common questions
What to know about Dendis Capital
Upseed classifies Dendis Capital under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.